Additional file 4: of Comparative effectiveness of anti-viral drugs with dual activity for treating hepatitis B and HIV co-infected patients: a network meta-analysis

Risk of bias assessment by the review authors. (DOC 33 kb

Additional file 5: of Comparative effectiveness of anti-viral drugs with dual activity for treating hepatitis B and HIV co-infected patients: a network meta-analysis

Treatment relative ranking. (DOC 31 kb

Additional file 2: of Comparative effectiveness of anti-viral drugs with dual activity for treating hepatitis B and HIV co-infected patients: a network meta-analysis

Excluded studies and reasons for exclusion. (DOC 38 kb

Additional file 1: of Comparative effectiveness of anti-viral drugs with dual activity for treating hepatitis B and HIV co-infected patients: a network meta-analysis

Citations and Ovid MEDLINE. (DOC 44 kb

Additional file 3: of Comparative effectiveness of anti-viral drugs with dual activity for treating hepatitis B and HIV co-infected patients: a network meta-analysis

Distribution of studies and comparisons. (DOC 40 kb